Document:

ptx_ex1019.htm

Exhibit 10.19

AMENDMENT NO. 1 TO

AMENDED AND RESTATED

EMPLOYMENT AND NON-COMPETE AGREEMENT

THIS AMENDMENT NO. 1 TO AMENDED AND RESTATED EMPLOYMENT AND NON-COMPETE AGREEMENT (this “Amendment”) is entered into and effective as of the 23rd day of March, 2012 (the “Effective Date”), by and among Macoven Pharmaceuticals, LLC, a Louisiana limited liability company (“Employer”), Pernix Therapeutics Holdings, Inc., a Maryland corporation and sole member of Employer (“Parent”) and John McMahon, a resident of the lawful age of majority of the Commonwealth of Kentucky (“Employee”), who hereby agree as follows:

WHEREAS, Employer, Employee and Parent entered into an Amended and Restated Employment and Non-Compete Agreement effective March 14, 2011 (the “Agreement”) to replace a prior Employment Agreement that is no longer in effect;

WHEREAS, the parties desire to amend the Agreement for the purpose of further creating an incentive component of Employee’s compensation package that better aligns the interests of Parent, Employer and Employee.

NOW, THEREFORE, in consideration of the premises and the mutual covenants hereinafter set forth and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Employer, Parent and Employee, intending to be legally bound, hereby agree as follows:

1. Removal of Certain Provisions; Issuance of Restricted Stock; Volume Limitation

(a) Section 3(d) of the Agreement is hereby deleted in its entirety, including subsections (i), (ii), (iii), (iv) and (v) thereof; and

(b) Section 4 of the Agreement is hereby deleted in its entirety.

(c) The first sentence of Section 5(a) of the Agreement is hereby amended and replaced in its entirety with the following:

“During the term of this Agreement, Employee shall not, during any calendar week, Transfer shares of Common Stock, regardless of whether Employee received such shares as compensation under this Agreement, that exceed the lesser of (1) 5,000 shares or (2) five percent (5%) of the average weekly trading volume of the Common Stock (as reported on NYSE Amex or such other exchange on which Common Stock may be listed) for the previous twelve completed calendar weeks prior to the proposed Transfer.”

(d) Parent agrees to grant Employee 165,000 restricted shares of its Common Stock pursuant to Parent’s Amended and Restated 2009 Stock Incentive Plan, with such shares to vest in three equal installments on each of the first three anniversaries of the date of grant of such shares and with such other terms and conditions contained in Parent’s current form of restricted stock agreement.

2. Agreement Still in Force.  The remaining provisions of the Agreement shall remain in full force and effect and are not effected by the provisions of this Amendment.

3. Defined Terms.  Any terms capitalized but not otherwise defined herein shall have the meaning ascribed to such terms in the Agreement.

4. Governing Law.  This Amendment shall be construed in accordance with, and governed by, the Laws of the Commonwealth of Kentucky applicable to agreements to be performed entirely in the Commonwealth of Kentucky without regard to its conflicts of law rules.

 

  

  

  

 

5. Headings.  The subject headings of the sections of this Amendment are included for purposes of convenience only, and shall not control or affect the meaning, construction or interpretation of any of its provisions.

6. Notice.  Any notice or other communication required or permitted under this Amendment by either party hereto to the other shall be in writing, and shall be deemed effective upon (a) personal delivery, if delivered by hand, (b) three days after the date of deposit in the mails, postage prepaid, if mailed by certified or registered mail, or (c) the next business day, if sent by a prepaid overnight courier service, and in each case addressed as follows:

If to Employee, to:                John McMahon

6204 Crystal Point Drive

Louisville, Kentucky 40299

If to Employer, to:                 Macoven Pharmaceuticals, LLC

10003 Woodloch Forest Drive

The Woodlands, Texas 77380

Attn: Cooper Collins

If to Parent, to:                      Pernix Therapeutics Holdings, Inc.

10003 Woodloch Forest Drive

The Woodlands, Texas 77380

Attn: Cooper Collins

Any party may change the address or addresses to which notices are to be sent by giving notice of such change of address in the manner provided by this Section.

7. Binding Effect; Successors.  This Amendment shall be binding upon and shall inure to the benefit of Employer and Parent and their respective successors and assigns, and shall inure to the benefit of and be binding upon Employee and his executors, administrators, heirs and legal representatives.  Because Employee’s services hereunder are special, personal and unique in nature, Employee may not transfer, sell or otherwise assign his rights, obligations or benefits under this Amendment.  Nothing in this Amendment shall preclude Employer and/or Parent from assigning, in full or part, this Amendment to any affiliate of Employer, or preclude Employer or Parent from consolidating or merging into or with, or transferring all or substantially all of its assets to, another entity which assumes its obligations under this Amendment in full.

8. Waiver.  No waiver of a default by either party of any term, covenant or condition hereof to be performed or observed by the other party shall be construed as, or operate as, a waiver of any subsequent default of the same or any other term, covenant or condition hereof.  No provision of this Amendment can be waived unless such waiver is expressed in writing and signed by all of the parties hereto.

9. No Conflict.  Employee represents and warrants that Employee is not subject to any agreement, order, judgment or decree of any kind which would prevent Employee from entering into this Agreement or performing fully Employee’s obligations hereunder.

10. Construction.  The language of this Amendment shall be construed as a whole, according to its fair meaning and intent and not strictly for or against any party, regardless of who drafted or was principally responsible for drafting the Amendment or any specific term or condition hereof.  The parties to this Amendment have had sufficient time to consult legal counsel and negotiate changes regarding the terms hereof.  This Amendment shall be deemed to have been drafted by both parties to this Amendment, and neither shall urge otherwise.

 

  

2

  

 

11. Severability.  The provisions of this Amendment are severable.  The parties intend that if any provision of this Amendment should be adjudged invalid or unenforceable in any jurisdiction, then such provision shall, as to such jurisdiction only, be ineffective to the extent of such invalidity or unenforceability without invalidating the remaining provisions hereof, provided such invalidity does not materially prejudice either party in its or his rights and obligations contained in the valid provisions of this Amendment, and any such invalidity or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.

 

12. Counterparts; Entire Agreement; Modification.  This Amendment may be executed in multiple counterparts, all of which together shall constitute one and the same instrument.  Signatures by facsimile shall be considered valid and binding on the parties hereto.  Together with the Agreement, this Amendment constitutes the entire agreement between the parties with respect to the subject matter hereof and, together with the Agreement, supersedes all prior and contemporaneous oral or written agreements, representations, and understandings of the parties.  No supplement, modification or amendment to this Amendment shall be binding unless executed in writing by all parties to this Agreement.

[COUNTERPART SIGNATURES ON THE FOLLOWING PAGES]

  

3

  

COUNTERPART SIGNATURE PAGE TO

AMENDMENT NO. 1 To

AMENDED AND RESTATED

EMPLOYMENT AND NON-COMPETE AGREEMENT

BY AND AMONG

MACOVEN PHARMACEUTICALS, LLC

PERNIX THERAPEUTICS HOLDINGS, INC.

AND

JOHN MCMAHON

 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date hereof.

 

	EMPLOYEE:	 	 	EMPLOYER:	 
	 	 	 	
MACOVEN PHARMACEUTICALS, LLC

By: PERNIX THERAPEUTICS, LLC

	 
	 	 	 	 	 
	 	 	 	By: PERNIX THERAPEUTICS HOLDINGS, INC.	 
	 	 	 	 	 
	
/s/ John McMahon

	 	 By:	
/s/ Cooper Collins

	 
	
John McMahon

	 	 Name:	
Cooper Collins

	 
	
 

	 	 Its:	
President and Chief Executive Officer

	 

 

	 AGREED AND ACKNOWLEDGED: 	 	 	PARENT:	 
	 EMPLOYEE’S SPOUSE:   	 	 	 	 
	 	 	 	PERNIX THERAPEUTICS HOLDINGS, INC.	 
	 	 	 	 	 
	
/s/ Kimberly McMahon

	 	 By:	
/s/ Cooper Collins

	 
	
Kimberly McMahon

	 	 Name:	
Cooper Collins

	 
	
 

	 	 Its:	
President and Chief Executive Officer

	 

 

4inuv_ex41.htm

EXHIBIT 4.1

 

 

NEITHER THESE SECURITIES NOR THE SECURITIES FOR WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE ACT AND IN COMPLIANCE WITH APPLICABLE STATE SECURITIES OR BLUE SKY LAWS.  THESE SECURITIES AND THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

WARRANT TO PURCHASE COMMON STOCK

	
Date of Issuance: As of August 1, 2009

	
Warrant to Purchase an Aggregate of 400,000 shares of Common Stock

FOR VALUE RECEIVED, Inuvo, Inc., a Nevada corporation (the “Corporation”), pursuant to the terms and conditions of that certain Consulting Services Agreement effective August 1, 2009 by and between the Corporation and Genesis Select Corporation (the "Holder") promises to issue in the name of, and sell and deliver to the Holder a certificate or certificates for up to an aggregate of FOUR HUNDRED THOUSAND (400,000) shares of the Corporation’s common stock, par value $0.001 per share (the “Common Stock”), following the vesting thereof upon payment by the Holder of the Exercise Prices set forth as follows.

This Warrant shall vest in 24 equal monthly increments of 16,666 shares each on the last day of each month with the initial 1/24th increment vesting on August 31, 2009. Of the total of 400,000 shares of the Corporation’s common stock which are issuable upon the exercise of this warrant following the vesting thereof, the first 100,000 shares shall be exercisable at $0.30 per share, the next 100,000 shares shall be exercisable at $0.50 per share, the next 100,000 shares shall be exercisable at $1.00 per share and the final 100,000 shares shall be exercisable at $1.50 per share, with each such the Exercise Price being subject to adjustment in the circumstances set forth below.

Section 1.

Exercise of Warrant

1.1           Exercise Period.  The Holder may exercise this Warrant, in whole or in part (but not as to fractional shares), at any time and time to time following the vesting of the various tranches thereof as set forth above and ending at 5:00 p.m., Eastern Time, on August 1, 2014 (the “Exercise Period”).

1.2           Exercise Procedure.

a.           This Warrant may be exercised in whole or in part at any time during the Exercise Period, provided however, if the last day of the Exercise Period is a day on which federal or state chartered banking institutions located in the State of Florida are authorized by law to close, then the last day of the Exercise Period shall be deemed to be the next succeeding day which shall not be such a day, by presentation and surrender to the Corporation at its principal office of this Warrant accompanied by the form of Exercise Agreement attached hereto as Exhibit 1 signed by the Holder and upon payment of the Exercise Price for the Common Stock purchased thereby, by cashier's check or by wire transfer of immediately available funds.

b.           Certificates for the shares of Common Stock purchased upon exercise of this Warrant will be delivered by the Corporation to the Holder within five (5) business days after the Exercise Date.  Unless this Warrant has expired or all of the purchase rights represented hereby have been exercised, the Corporation will prepare a new Warrant representing the rights formerly represented by this Warrant that have not expired or been exercised.  The Corporation will, within such five (5) day period, deliver such new Warrant to the Holder at the address set forth in this Warrant.

c.           The shares of Common Stock issuable upon the exercise of this Warrant will be deemed to have been transferred to the Holder on the Exercise Date, and the Holder will be deemed for all purposes to have become the record holder of such Common Stock on the Exercise Date.

d.           The issuance of certificates for shares of Common Stock upon the exercise of this Warrant will be made without charge to the Holder of any issuance tax in respect thereof or any other cost incurred by the Corporation in connection with such exercise and related transfer of the shares; provided, however, that the Corporation shall not be required to pay any tax that may be payable in respect of any transfer involved in the issuance and delivery of any certificate or instrument in a name other than that of the Holder of this Warrant, and that the Corporation shall not be required to issue or deliver any such certificate or instrument unless and until the person or persons requiring the issue thereof shall have paid to the Corporation the amount of such tax or shall have established to the satisfaction of the Corporation that such tax has been paid.

e.           Unless the shares of Common Stock issuable upon the exercise of this Warrant have been registered under the Securities Act of 1933, as amended (the “Act”) such shares will be “restricted securities” as that term is defined in the Act. The Corporation may insert the following or similar legend on the face of the certificates evidencing shares of Common Stock if required in compliance with state securities laws:

"These securities have not been registered under any state securities laws and may not be sold or otherwise transferred or disposed of except pursuant to an effective registration statement under any applicable state securities laws, or an opinion of counsel satisfactory to counsel to the Corporation that an exemption from registration under any applicable state securities laws is available."

 

 

1.3           Fractional Shares.  If a fractional share of Common Stock would, but for the provisions of Subsection 1.1, be issuable upon exercise of the rights represented by this Warrant, the Corporation will, within 30 days after the Exercise Date, deliver to the Holder a check payable to the Holder, in lieu of such fractional share, in an amount equal to the market price of such fractional share as determined by the last sale price of the Corporation’s Common Stock as reported on the NYSE Amex or the principal exchange on which the Corporation’s Common Stock is then traded, as of the close of business on the Exercise Date.

  

  

  

Section 2.

Effect of Stock Dividends, Reorganization, Reclassification,

Consolidation, Merger or Sale

2.1           Stock Dividends, Recapitalization or Reclassification of Common Stock.  In case the Corporation shall at any time prior to the exercise or termination of this Warrant (i) pay a dividend or make a distribution of its capital stock in shares of Common Stock to all holders of shares of Common Stock, or (ii) effect a recapitalization or reclassification of such character that its Common Stock shall be changed into or become exchangeable for a larger or smaller number of shares, then, upon the effective date thereof, the number of shares of Common Stock that the Holder of this Warrant shall be entitled to purchase upon exercise hereof shall be increased or decreased, as the case may be, in direct proportion to the increase or decrease in such number of shares of Common Stock by reason of such stock dividend, recapitalization or reclassification, and the Exercise Price of such dividend, recapitalized or reclassified Common Stock shall, in the case of an increase in the number of shares, be proportionately decreased and, in  the  case  of  a  decrease  in  the  number  of  shares,  be proportionately increased.

2.2           Consolidation, Merger or Sale.  In case the Corporation shall at any time prior to the exercise of this Warrant, or the expiration of the Exercise Period, whichever first occurs, consolidate or merge with any other corporation (unless the Corporation shall be the surviving entity) or transfer all or substantially all of its assets to any other corporation preparatory to a dissolution, then the Corporation shall, as a condition precedent to such transaction, cause effective provision to be made so that the Holder of this Warrant, upon the exercise thereof after the effective date of such transaction, shall be entitled to receive the kind and amount of shares, evidences of indebtedness, and/or other property receivable on such transaction by a holder of the number of shares of Common Stock as to which the Warrant was exercisable immediately prior to such transaction (without giving effect to any restriction upon such exercise); and, in any such case, appropriate provision shall be made with respect to the rights and interests of the Holder hereof to the effect that the provisions of this Warrant shall thereafter be applicable (as nearly as may be practicable) with respect to any shares, evidences of indebtedness, or other securities or assets thereafter deliverable upon exercise of this Warrant.

2.3           Notice of Adjustment.  Whenever the number of shares of Common Stock purchasable upon exercise of this Warrant shall be adjusted as provided herein, the Corporation shall file with its corporate records a certificate of its Chief Financial Officer setting forth the computation and the adjusted number of shares of Common Stock purchasable hereunder resulting from such adjustments, and a copy of such certificate shall be mailed to the Holder.  Any such certificate or letter shall be conclusive evidence as to the correctness of the adjustment or adjustments referred to therein and shall be available for inspection by the holders of the Warrants on any day during normal business hours.

Section 3.

Reservation of Common Stock

The Corporation will at all time reserve and keep available such number of shares of Common Stock as will be sufficient to permit the exercise in full of this Warrant.  Upon exercise of this Warrant pursuant to its terms, the Holder will acquire fully paid and non-assessable ownership rights of the Common Stock, free and clear of any liens, claims or encumbrances.

  

  

  

Section 4.

No Stockholder Rights or Obligations

This Warrant will not entitle the Holder hereof to any voting rights or other rights as a stockholder of the Corporation.  Until the shares of Common Stock issuable upon the exercise of this Warrant are recorded as issued on the books and records of the Corporation’s transfer agent, the Holder shall not be entitled to any voting rights or other rights as a stockholder; provided, however, that the Corporation shall use its bests efforts to ensure that, upon receipt of the Exercise Agreement and payment of the Exercise Price, the appropriate documentation necessary to effectuate the exercise of the Warrant and the issuance of the Common Stock is accomplished as expeditiously as possible.  No provision of this Warrant, in the absence of affirmative action by the Holder to purchase Common Stock, and no enumeration in this Warrant of the rights or privileges of the Holder, will give rise to any obligation of such Holder for the Exercise Price or as a stockholder of the Corporation.

Section 5.

Transferability

This Warrant and any rights hereunder are transferable, in whole or in part, by the Holder with the prior written consent of the Corporation, which such consent shall not be unreasonably withheld.  In the event the Corporation should consent to such transfer, this Warrant and the rights under shall be transferable upon surrender of this Warrant with a properly executed Assignment in the form of Exhibit 2 hereto at the principal offices of the Corporation.  The Corporation has no obligation to recognize any purported transfer of this Warrant, and the transferee is not entitled to any rights under this Warrant, until such acknowledgment has been received by the Corporation.  This Warrant and the underlying shares of Common Stock may not be offered, sold or transferred except in compliance with the Act, and any applicable state securities laws, and then only against receipt of an agreement of the person to whom such offer or sale or transfer is made to comply with the provisions of this Warrant with respect to any resale or other disposition of such securities; provided that no such agreement shall be required from any person purchasing this Warrant or the underlying shares of Common Stock pursuant to a registration statement effective under the Act.  The Holder of this Warrant agrees that, prior to the disposition of any security purchased on the exercise hereof other than pursuant to a registration statement then effective under the Act, or any similar statute then in effect, the Holder shall give written notice to the Corporation, expressing his intention as to such disposition.  Upon receiving such notice, the Corporation shall present a copy thereof to its securities counsel.  If, in the sole opinion of such counsel, which such opinion shall not be unreasonably withheld, the proposed disposition does not require registration of such security under the Act, or any similar statute then in effect, the Corporation shall, as promptly as practicable, notify the Holder of such opinion, whereupon the Holder shall be entitled to dispose of such security in accordance with the terms of the notice delivered by the Holder to the Corporation.

Section 6.

Registration Rights

The Corporation hereby grants the following registration rights to Holder of this Warrant:

6.1           Demand Registration.  On one occasion, for a period commencing on August 1, 2013 and continuing until the expiration date of this Warrant, upon a written request therefor from the Holder, the Corporation shall prepare and file with the United States Securities and Exchange Commission (the “Commission”) a registration statement under the Act registering the shares of Common Stock underlying any unexercised portion of this Warrant (the “Registerable Securities”) which are the subject of such request for unrestricted public resale by the Holder or any permitted assignee of this Warrant pursuant to the provisions of Section 5 hereof.  For purposes of Section 6, Registerable Securities shall not include shares of Common Stock which are (A) registered for resale in an effective registration statement, (B) included for registration in a pending registration statement, (C) which have been issued without further transfer restrictions after a sale or transfer pursuant to Rule 144 under the Act or (D) which may be resold under Rule 144

6.2           Piggy-back Registration.  If the Company at any time proposes to register any of its securities under the Act for sale to the public, whether for its own account or for the account of other security holders or both, except with respect to registration statements on Forms S-4, S-8 or another form not available for registering the Registerable Securities for sale to the public, each such time it will give at least ten (10) days' prior written notice to Holder of the Registerable Securities of its intention so to do. Upon the written request of the Holder, received by the Corporation within ten (10) days after the giving of any such notice by the Corporation, to register any of the Registerable Securities not previously registered, the Corporation will cause such Registerable Securities as to which registration shall have been so requested to be included with the securities to be covered by the registration statement proposed to be filed by the Corporation, all to the extent required to permit the sale or other disposition of the Registerable Securities so registered by the Holder of such Registerable Securities. In the event that any registration pursuant to this Section 6.2 shall be, in whole or in part, an underwritten public offering of common stock of the Corporation or securities convertible or exchangeable into shares of Common Stock of the Corporation, the number of shares of Registerable Securities to be included in such an underwriting may be reduced by the managing underwriter if and to the extent that the Corporation and the underwriter shall reasonably be of the opinion that such inclusion would adversely affect the marketing of the securities to be sold by the Corporation therein; provided, however, that the Corporation shall notify the Holder in writing of any such reduction. Notwithstanding the foregoing provisions, the Corporation may withdraw or delay or suffer a delay of any registration statement referred to in this Section 6.2 without thereby incurring any liability to the Holder.

6.3           Costs of Registration.  The Corporation shall pay all costs associated with the preparation and filing of the registration statements pursuant to either Section 6.1 or 6.2 hereof, except that the Holder shall be obligated to pay the fees and costs of its counsel, if any, and any commissions or discounts incurred in the sale of the Registerable Securities.

Section 7.

Miscellaneous

7.1           Notices.  Any notices, requests or consents hereunder shall be deemed given, and any instruments delivered, two days after they have been mailed by first class mail, postage prepaid, or upon receipt if delivered personally or by facsimile transmission, as follows:

If to the Corporation:                                           15550 Lightwave Drive

Third Floor

Clearwater, FL  33760

If to the Holder:                                           2005 10th Street, Suite D

Boulder, CO 80302

except that any of the foregoing may from time to time by written notice to the other designate another address which shall thereupon become its effective address for the purposes of this paragraph.

7.2           Entire Agreement.  This Warrant, including the exhibits and documents referred to herein which are a part hereof, contain the entire understanding of the parties hereto with respect to the subject matter and may be amended only by a written instrument executed by the parties hereto or their successors or assigns.  Any paragraph headings contained in this Warrant are for reference purposes only and shall not affect in any way the meaning or interpretation of this Warrant.

7.3           Construction and Enforcement.  This Warrant shall be governed by and construed under the laws of the State of Florida, without regard to principles of conflicts of laws and rules of such state. If it becomes necessary for any party to institute legal action to enforce the terms and conditions of this Warrant, and such legal action results in a final judgment in favor of such party ("Prevailing Party"), then the party or parties against whom said final judgment is obtained shall reimburse the Prevailing Party for all direct, indirect or incidental expenses incurred, including, but not limited to, all attorneys’ fees, court costs and other expenses incurred throughout all negotiations, trials or appeals undertaken in order to enforce the Prevailing Party's rights hereunder.  Any suit, action or proceeding with respect to this Warrant shall be brought in the state or Federal courts located in Pinellas County in the State of Florida.  The parties hereto hereby accept the exclusive jurisdiction and venue of those courts for the purpose of any such suit, action or proceeding.  The parties hereto hereby irrevocably waive, to the fullest extent permitted by law, any objection that any of them may now or hereafter have to the laying of venue of any suit, action or proceeding arising out of or relating to this Warrant or any judgment entered by any court in respect thereof brought in Pinellas County, Florida, and hereby further irrevocably waive any claim that any suit, action or proceeding brought in Pinellas County, Florida, has been brought in an inconvenient forum.

IN WITNESS WHEREOF, this Warrant has been duly executed and the corporate seal affixed hereto, all as of the day and year first above written.

INUVO, INC.

By:___ ________________

Richard K. Howe, President

ATTEST:

________________________

  

  

  

EXHIBIT 1

EXERCISE AGREEMENT

To:                                                                                                                     Dated:

The undersigned record Holder, pursuant to the provisions set forth in the within Warrant, hereby subscribed for and purchases   shares of Common Stock covered by such Warrant and hereby makes full cash payment of $  for such shares at the Exercise Price provided by such Warrant.

____________________________

(Signature)

____________________________

(Print or type name)

____________________________

(Address)

NOTICE: The signature of this Exercise Agreement must correspond with the name as written upon the face of the within Warrant, or upon the Assignment thereof, if applicable, in every particular, without alteration, enlargement or any change whatsoever.

  

  

  

EXHIBIT 2

ASSIGNMENT

FOR VALUE RECEIVED,  , the undersigned Holder hereby sell, assigns, and transfer all of the rights of the undersigned under the within Warrant with respect to the number of shares of Common Stock issuable upon the exercise of such Warrant set forth below, unto the Assignee identified below, and does hereby irrevocable constituted and appoint   to effect such transfer of rights on the books of the Corporation, with full power of substitution:

	
Name of Assignee

	
Address of Assignee

	
Number of Shares of Common Stock

	  	  	  
	  	  	  
	  	  	  

Dated:                                                        _________________________

(Signature of Holder)

______________________________________

(Print or type name)

NOTICE: The signature of this Exercise Agreement must correspond with the name as written upon the face of the within Warrant, or upon the Assignment thereof, if applicable, in every particular, without alteration, enlargement or any change whatsoever.

CONSENT OF ASSIGNEE

I HEREBY CONSENT to abide by the terms and conditions of the within Warrant.

Dated: 

_____________________________________

(Signature of Assignee)

_____________________________________

(Print or type name)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00202-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00202-of-00352.parquet"}]]